<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99337">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02156258</url>
  </required_header>
  <id_info>
    <org_study_id>FMSU2013-004A</org_study_id>
    <nct_id>NCT02156258</nct_id>
  </id_info>
  <brief_title>Acquisition of Breast Mammography Images</brief_title>
  <official_title>Acquisition of Digital Mammography and Breast Images for Clinical Evaluation of FujifilmDigital Breast Tomosynthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fujifilm Medical Systems USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fujifilm Medical Systems USA, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a case collection study of breast images using standard and new mammography
      technology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This image acquisition study is designed to acquire the study image data and establish and
      document the clinical findings for each subject. This study will create a library of image
      data that will be used for future projects.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Case Collection of Mammography Images with Breast Cancer</measure>
    <time_frame>20 Months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Case Collection of Mammography Images that Required Recall with No Cancer</measure>
    <time_frame>20 Months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Case Collection of Mammography Images with No Cancer</measure>
    <time_frame>20 Months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Cancer Cases</arm_group_label>
    <description>Collection of cancer cases using Full Field Digital Mammography (FFDM) Mammography and Digital Breast Tomosynthesis (DBT) Mammography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Recall Cases</arm_group_label>
    <description>Collection of Imaging Recall Cases using FFDM Mammography and DBT Mammography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Cancer Cases</arm_group_label>
    <description>Collection of Non-Cancer Cases using FFDM Mammography and DBT Mammography</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FFDM Mammography</intervention_name>
    <description>Standard mammography image collection</description>
    <arm_group_label>Cancer Cases</arm_group_label>
    <arm_group_label>Recall Cases</arm_group_label>
    <arm_group_label>Non-Cancer Cases</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DBT Mammography</intervention_name>
    <description>Collection of breast images using DBT mammography</description>
    <arm_group_label>Cancer Cases</arm_group_label>
    <arm_group_label>Recall Cases</arm_group_label>
    <arm_group_label>Non-Cancer Cases</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of at least 200 cancer, 175 recall cases and 350 negative/benign cases will be
        accumulated
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For Screening Subjects

          -  Be at least 40 years of age, are

          -  Asymptomatic,

          -  Scheduled for a routine screening mammogram

        For Diagnostic Subjects

          -  Be at least 18 years of age,

          -  Scheduled for a biopsy due to an assessment of Breast Imaging and Reporting Data
             (BI-RADSÂ®) 4 or 5 after diagnostic work-up of a suspicious screening or clinical
             finding within the last 60 days.

          -  Understand requirements and willing to participate in study

        Exclusion Criteria:

          -  Presence of a breast implant.

          -  Women with only a single breast; for example, post mastectomy patients.

          -  Is pregnant or believes she may be pregnant.

          -  A woman who has delivered and who has expressed the intention to breast-feed or is
             currently breast-feeding.

          -  A woman who has significant existing breast trauma within the last one year.

          -  Have self-reported severe non-focal or bilateral breast pain affecting subject's
             ability to tolerate digital mammography and/or breast tomosynthesis examinations.

          -  A woman who has had a mammogram performed for the purpose of therapy portal planning
             within the last year.

          -  Cannot, for any known reason, undergo follow-up digital mammography and/or breast
             tomosynthesis examinations (where clinically indicated) at the participating
             institution.

          -  Is an inmate (see US Code of Federal Regulations 45CFR46.306).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Etta D Pissano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jesse Lin, PhD</last_name>
    <phone>301.251.992</phone>
    <email>jlin@fujifilm.com</email>
  </overall_contact>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 3, 2014</lastchanged_date>
  <firstreceived_date>June 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Imaging</keyword>
  <keyword>Mammography</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
